Any communication by, or on behalf of, the manufacturer, distributor, or retailer of a nicotine product, which indicates that the product contains a nicotine analog, constitutes presumptive evidence that the product contains a nicotine analog. Source: SL 2026, ch 54 , § 3, eff. Jan. 1, 2027. Effective January 1, 2027